Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

celgene_1_02

Celgene bucks trend to strengthen neuroscience pipeline

March 21, 2018 Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical

Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …
News
shutterstock_38078521

Heron soars after its painkiller agent reduces pain and opioid use post-surgery at Phase 3

March 20, 2018 Manufacturing and Production, Research and Development heron therapeutics, opioid crisis, opioid epidemic, opioids, painkiller, pharma

Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary …
News
regeneron

Regeneron’s Eylea smashes Phase 3 trial goal in diabetic retinopathy

March 20, 2018 Manufacturing and Production, Research and Development Eylea, Regeneron, diabetes, pharma

Regeneron has confirmed that its vascular endothelial growth factor (VEGF) inhibitor injection Eylea (aflibercept) met its primary endpoint in a …
News
rocheroof

Roche’s immunotherapy improves PFS but unclear long-term benefit in lung cancer

March 20, 2018 Manufacturing and Production, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Roche’ Tecentriq needs a big result in the immunotherapy space – it initially burst onto the scene as a third-to-market …
News
john_mchutchison

New Chief Science and Medical Officers for Gilead

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …
Appointment
sperium-2505952_960_720

Male contraceptive pill hits safety goals

March 19, 2018 Research and Development, Sales and Marketing biotech, drugs, male contraceptive, pharma, pharmaceutical

A male contraceptive pill may be edging closer to the market, after a new formulation was shown to be safe …
News

Working Life: Chris Round, Head of EMEA Region, Merck KGaA

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma

Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …
Feature
stem-cell-163711_640

“Game-changer” stem cell transplant shows strength in multiple sclerosis

March 19, 2018 Research and Development, Sales and Marketing Stem cells, multiple sclerosis, pharma

A new stem cell transplant is being hailed as a “game-changer” in the treatment of multiple sclerosis (MS) after an …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten

Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …
News
ears-2545756_960_720

Hearing drug failure puts biotech on brink

March 16, 2018 Medical Communications, Research and Development Auris, biotech, drugs, pharma, pharmaceutical

Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …
News
12_rare

The need for flexible appraisal of rare disease medicines

March 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, feature, pharma, rare disease, rare diseases

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …
Feature
fda_sign_web

Solid Biosciences rocked by clinical hold, shareholders flee

March 15, 2018 Research and Development Solid Biosciences, biotech, drugs, pharma, pharmaceutical

Solid Biosciences raised more than a few eyebrows when it only revealed a partial hold from the FDA stalling its …
News
william_pao

Roche appoints new research and early development head

March 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, appointment

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …
Appointment
saroukos

Takeda’s CFO departs forcing company to act

March 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …
Appointment
teva_copy

Teva denies wrongdoing in Cephalon pay-to-delay deal hearing

March 14, 2018 Research and Development, Sales and Marketing Cephalon, Pay to delay, Provogil, Teva, pay-to-delay, pharma

Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025